Skip to main content
DeutschDE
European Commission logo print header

Histone acetyl-transferases and deacetylases : new target for cancer therapy

Ziel

The balance between cell proliferation and differentiation, which deregulation is central to carcinogenesis, is controlled through the interactions between key proteins. These proteins are sensitive to gain-of-function or loss-of-function mutations in cancer, and thus represent potential targets for cancer therapy. Recent basic advances on cell-fate controlling regulatory pathways have demonstrated a key role for histone acetyl-transferases (HATs) and histone deacetylases (HDs).

The objectives are:
1- to further characterise, at the molecular level, regulatory pathways involving HATs / HDs in normal cells;
2- to analyse HATs / HDs in cancer cells;
3- to demonstrate that restoring normal function of these enzymes in cancer cells, by modifying their interaction with other proteins, reverses the phenotype.

After completion of these steps, drug screening will be set up to reveal new drugs directed against these enzymes.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

CSC - Cost-sharing contracts

Koordinator

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
EU-Beitrag
Keine Daten
Adresse
19 rue Guy MOQUET
94801 VILLEJUIF
Frankreich

Auf der Karte ansehen
Gesamtkosten
Keine Daten

Beteiligte (5)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 9 Dezember 2005

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/QLG1-CT-1999-00866/de

European Union, 2024